Burden of asthma by severity and exacerbation frequency among adult patients naive to biologic asthma therapy: A Finnish cohort study
Despite improved outcomes in asthma over the past decades, a substantial proportion of patients experience frequent exacerbations. These patients are multimorbid and at increased risk of mortality. Exacerbation frequency, rather than asthma severity, seems to be the main factor associated with an increased disease burden. Clinical awareness should be raised to improve the management and outcomes for these patients.
Authors
- Arja Viinanen (ORCID: https://orcid.org/0000-0003-4990-6228)
- Annina Lyly (ORCID: https://orcid.org/0000-0001-7221-1227)
- Hannu Kankaanranta (ORCID: https://orcid.org/0000-0001-5258-0906)
- Helga Haugom Olsen (ORCID: https://orcid.org/0000-0002-2043-5154)
- Paula Kauppi (ORCID: https://orcid.org/0000-0002-1065-330X)
- Mariann I. Lassenius (ORCID: https://orcid.org/0000-0003-0511-3939)
- Kaisa Nieminen
- Lauri Lehtimäki (ORCID: https://orcid.org/0000-0003-1586-4998)
- Anton Klåvus
Institutions
- University of Helsinki (FI)
- University of Turku (FI)
- Tampere University (FI)
- Seinäjoki University of Applied Sciences (FI)
- Helsinki University Hospital (FI)
- Turku University Hospital (FI)
- Tampere University Hospital (FI)
- AstraZeneca (Switzerland) (CH)
- Tampere University (FI)
- AstraZeneca (Finland) (FI)
- University of Gothenburg (SE)
Publication Details
- Journal
- Journal of Allergy and Clinical Immunology Global
- Published
- 2025-03-14
- DOI
- https://doi.org/10.1016/j.jacig.2025.100453
- Citations
- 4
- Primary Topic
- Asthma and respiratory diseases
- Type
- article
- Field-Weighted Citation Impact
- 4.66